Clincosm LogoSign in Get a demo

Applying Moziak Device Compared to Standard Manual Compression on Arterio-Venous Fistula Puncture Sites Haemostasis

Sponsor
Beni-Suef University (Other)
Overall Status
Completed
CT.gov ID
NCT05463315
Collaborator
(none)
96
Enrollment
1
Location
1
Arm
4.4
Actual Duration (Months)
22
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study aimed to evaluate the Effectiveness of Applying Moziak Device Compared to Standard Manual Compression Post Dialysis Arterio-Venous Fistula Puncture Sites Haemostasis

Condition or Disease Intervention/Treatment Phase
  • Device: Moziak Device
 N/A

Detailed Description

application of new device to find a Solution for Nursing Challenge for caring patient Post Dialysis Arterio-Venous Fistula Puncture Sites Haemostasis

Study Design

Study Type:
Interventional
Actual Enrollment :
96 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A Mixed Methods Sequential Explanatory StudyA Mixed Methods Sequential Explanatory Study
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Mixed Methods Sequential Explanatory Study to Evaluate the Effectiveness of Applying Moziak Device Compared to Standard Manual Compression on Arterio-Venous Fistula Puncture Sites Haemostasis
Actual Study Start Date :
Jul 20, 2021
Actual Primary Completion Date :
Oct 30, 2021
Actual Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Moziak Device

Applying Moziak Device Compared to Standard Manual Compression

Device: Moziak Device
Applying Moziak Device Compared to Standard Manual Compression
Other Names:
  • Standard Manual Compression

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Change the time of Haemostasis post dialysis [3 months]

      Applying Moziak Device Compared to Standard Manual Compression Post Dialysis Arterio-Venous Fistula Puncture Sites

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • All patients undergoing hemodialysis therapy

    • Both sex

    Exclusion Criteria:

    • Less than 18 years old

    • Patient has central vascular access

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mansoura University Hospital Mansoura Egypt

    Sponsors and Collaborators

    • Beni-Suef University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Magda Bayoumi, Assisstant Professor, Beni-Suef University
    ClinicalTrials.gov Identifier:
    NCT05463315
    Other Study ID Numbers:
    • NURSING119
    First Posted:
    Jul 18, 2022
    Last Update Posted:
    Jul 20, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Arteriovenous Fistula
    Fistula

    Study Results

    No Results Posted as of Jul 20, 2022